The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.
about
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraHemolytic uremic syndrome: new developments in pathogenesis and treatmentA case of hemolytic uremic syndrome caused by Escherichia coli O104:H4Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimersSerotypes, intimin variants and other virulence factors of eae positive Escherichia coli strains isolated from healthy cattle in Switzerland. Identification of a new intimin variant gene (eae-eta2).Identification of four fimbria-encoding genomic islands that are highly specific for verocytotoxin-producing Escherichia coli serotype O157 strains.Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp.Shiga toxin-producing Escherichia coli infection.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.Childhood hemolytic uremic syndrome, United Kingdom and Ireland.Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002.Haemolytic uraemic syndrome: an overview.The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina.Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection.A novel antimicrobial peptide significantly enhances acid-induced killing of Shiga toxin-producing Escherichia coli O157 and non-O157 serotypes.Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children.Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.Seasonal association of thrombotic thrombocytopenic purpura.Study Prevalence of Verotoxigenic E.coli Isolated from Urinary Tract Infections (UTIs) in an Iranian Children Hospital.Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet.Strategies for surveillance of pediatric hemolytic uremic syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000-2007.An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.Multistate outbreak of Escherichia coli O145 infections associated with romaine lettuce consumption, 2010.Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.Evolution of enterohemorrhagic escherichia coli O26 based on single-nucleotide polymorphisms.Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104Hemorrhagic Stroke in an Adolescent Female with HIV-Associated Thrombotic Thrombocytopenic PurpuraTemporal and spatial patterns of bovine Escherichia coli O157 prevalence and comparison of temporal changes in the patterns of phage types associated with bovine shedding and human E. coli O157 cases in Scotland between 1998-2000 and 2002-2004.Derivation of Escherichia coli O157:H7 from its O55:H7 precursor.Enterohaemorrhagic Escherichia coli haemolysin is cleaved and inactivated by serine protease EspPαCharacterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.Characterization of a shiga toxin-, intimin-, and enterotoxin hemolysin-producing Escherichia coli ONT:H25 strain commonly isolated from healthy cattle.A brief overview of Escherichia coli O157:H7 and its plasmid O157.
P2860
Q24241470-3EB768C3-764E-4C42-A2F7-A902E12A1E74Q24613517-5CE4C808-5665-4872-AE80-1BD0EDE0A556Q24654024-6E2F992C-612E-4431-B4A9-B762A8E16648Q24669689-E16C1F77-30AB-47A2-B8BA-C21DE17FE0ACQ24810190-93518C29-FB53-4692-926B-8C988CA1D619Q33221148-B95BD164-1FFF-4225-BCCA-4FC0342236EEQ33302118-2034B2AC-EECD-4D37-A7DD-73B53D879776Q33346135-6A5EEA17-72A2-4AA9-BAC5-E12D0C2E7E7BQ33358383-0DFAB7E4-F758-4C5A-AB15-793A99B2EB99Q33360681-0CCA7F18-6E49-43FE-BDB3-23E8E08EF4BDQ33363266-5BF8AA37-DFEC-4DFC-A68E-04C1A21EE933Q33364280-DE67B698-0331-4F8E-BDDC-BA900482F1D8Q33365828-7393D57C-53F3-40FE-B3B8-93B7679BDE1CQ33365831-B98FFD7B-4A5C-4040-B7F6-BA770FB8AB13Q33371444-26EEFEFD-C5A4-4C96-A02C-ACF47ED55F76Q33373301-7847563F-7E3E-4EFD-A967-B39481B51AA2Q33379409-89D627E1-A998-4B38-BA3A-10F74FB74B4AQ33379683-B71226E9-8CC7-4FFC-AA17-4E4B0A450DBDQ33380835-608C2C54-EB7A-45AD-A0E3-4FDA4DBCD510Q33394720-DFFE49FC-BB29-4C96-83E6-4E29C3771360Q33396329-FAE631CC-D5DC-4921-806B-402FE1430169Q33396410-F5C5558E-FFB1-43B6-A50E-07E65B6EAA13Q33398432-7FAC7536-72D2-4278-9C97-81234FF05D93Q33399175-6C5F4478-6CB8-4EE6-90A2-7317A8F5F26EQ33399409-13059AA3-86BA-496E-BC42-6A52F1FBABDAQ33400197-90541832-7DB9-4498-943D-925FA9ADE513Q33401142-97524AD7-E70F-4D75-B2BA-0434FD5DE18BQ33401628-86D887D3-BA5A-438E-BF07-148B6E883F81Q33403923-8352A679-0051-4920-87B6-53F291E657B8Q33408119-5857AB28-5DED-4509-B425-49A10185F333Q33410364-3DDB5C65-FBF9-4E42-9347-B5C7C3E881CBQ33410817-DF39BB98-711E-4824-8CBD-0508C364FDAAQ33411533-EFD47825-2093-4F4D-9144-BD4F8486F5CBQ33418894-62EA9B89-A997-4DD9-92E9-216808A460BCQ33521123-B495CA82-0809-40DD-A8AB-409477C1AA94Q33525518-6E844524-98C0-4972-91AB-3AA0A7FFCD58Q33830049-FB08C694-F979-4A86-9C39-C6855D156762Q33883354-05690099-755E-422A-B3EC-BD52D5C4AE4BQ33884882-1F231ED1-2224-4833-93D8-7D73E72CB44DQ34097110-DA7417B8-E478-4E5A-97FE-7DF73F469819
P2860
The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The United States National Pro ...... l, and epidemiologic findings.
@ast
The United States National Pro ...... l, and epidemiologic findings.
@en
The United States National Pro ...... l, and epidemiologic findings.
@nl
type
label
The United States National Pro ...... l, and epidemiologic findings.
@ast
The United States National Pro ...... l, and epidemiologic findings.
@en
The United States National Pro ...... l, and epidemiologic findings.
@nl
prefLabel
The United States National Pro ...... l, and epidemiologic findings.
@ast
The United States National Pro ...... l, and epidemiologic findings.
@en
The United States National Pro ...... l, and epidemiologic findings.
@nl
P2093
P356
P1476
The United States National Pro ...... l, and epidemiologic findings.
@en
P2093
Hemolytic Uremic Syndrome Study Collaborators
K D Greene
N Banatvala
P M Griffin
T J Barrett
P304
P356
10.1086/319269
P407
P577
2001-03-01T00:00:00Z